Sibiriline

CAS No. 1346526-26-8

Sibiriline( Sibiriline )

Catalog No. M11395 CAS No. 1346526-26-8

A specific competitive RIPK1 inhibitor with IC50 of 1.03 uM, 100-fold less potent for RIPK3.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Sibiriline
  • Note
    Research use only, not for human use.
  • Brief Description
    A specific competitive RIPK1 inhibitor with IC50 of 1.03 uM, 100-fold less potent for RIPK3.
  • Description
    A specific competitive RIPK1 inhibitor with IC50 of 1.03 uM, 100-fold less potent for RIPK3; inhibits both TNF-induced RIPK1-dependent necroptosis and RIPK1-dependent apoptosis in FADD-deficient Jurkat cells (EC50=1.2 uM); selectively inhibits necroptotic cell death induced by various death ligands in human or mouse cells while not protecting from caspase-dependent apoptosis; protects mice from concanavalin A-induced hepatitis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Sibiriline
  • Pathway
    Apoptosis
  • Target
    RIP kinase
  • Recptor
    RIP kinase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1346526-26-8
  • Formula Weight
    210.236
  • Molecular Formula
    C13H10N2O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC1=CC=C(C2=CC3=CC=CN=C3N2)C=C1
  • Chemical Name
    4-(1H-Pyrrolo[2,3-b]pyridin-2-yl)phenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Le Cann F, et al. FEBS J. 2017 Jul 17. doi: 10.1111/febs.14176.
molnova catalog
related products
  • Oditrasertib

    Oditrasertib (DNL-788) is a potent RIPKl inhibitor with an IC50 value of less than 100 nM.

  • GSK547

    GSK547 (RIP1i, GSK 547) is a highly selective and potent inhibitor of RIP1 kinase that robustly targets RIP1 in vivo.

  • GSK-872

    GSK-872 (GSK 872) is a potent and selective RIPK3 (receptor-interacting protein kinase-3) inhibitor.